UK Spending £2.9bn On Seven COVID-19 Vaccines

Manufacturing Capacity Is Being Scaled Up

The UK government says it is on track to vaccinate the 15 million most vulnerable people by mid-February, and that a “major study” is under way to assess the potential impact of the new UK variant on vaccine efficacy.

3D illustration of Pfizer BionTech Moderna COVID 19 Vaccine approved in Britain England United Kingdom. Corona Virus SARS CoV 2, 2020 2021 nCoV vaccin delivery on UK flag background.
The UK is stepping up its coronavirus vaccination schedule • Source: Shutterstock

The UK has so far secured access to 367 million doses of COVID-19 vaccine from seven companies, at an expected cost of £2.9bn ($4bn) across the five final contracts that have been signed to date.

The government has made available more than £6bn in total to develop and procure COVID-19 vaccines, according to the vaccine delivery plan published by the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe